ImageneBio, Inc. (IMA) Form 424B3 — Jun 29, 2026
ImageneBio, Inc. filed a prospectus supplement relating to the proposed offer and resale of 2,508,337 shares of common stock by selling stockholders. The supplement updates the prospectus dated April 2, 2026, to include information from a Form 8-K filed on June 26, 2026. The incorporated Form 8-K discloses the resignation of Robert Lally, Senior Vice President of Finance and Operations and principal accounting officer, effective July 22, 2026.
Key figures
- Shares Offered
- 2508337
- Par Value
- $0.001
- Last Reported Sale Price
- $6.02
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.